Govt Job for M.Pharm to work in ICMR funded project

The Birla Institute of Technology & Science, BITS Pilani is an all-India Institute for higher education. The primary motive of BITS is to “train young men and women able and eager to create and put into action such ideas, methods, techniques and information”.

The Institute is a dream come true of its founder late Mr G.D.Birla – an eminent industrialist, a participant in Indian freedom struggle and a close associate of the Father of Indian Nation late Mr. Mohandas Karamchand Gandhi (Mahatma Gandhi).

Applications are invited from suitable candidates for Junior Research Fellow (JRF) to work on the following project sponsored by ICMR, under the supervision of Prof. Rajeev Taliyan, Department of Pharmacy, BITS-Pilani, Pilani Campus, Rajasthan

Title of the project : Exploring the mechanism(s) of gut microbiota link to Parkinson Disease pathology and its reversal based on fibroblast growth factor 21 gene delivery through lentivirus system

Fellowship amount : 31000/- per month

Eligibility requirements : M.Pharm / M.S. (Pharm.) in Pharmacology / Pharmaceutics, Pharmaceutical technology and Pharm. Analysis with GATE / GPAT / CSIR-NET / DST-INSPIRE or equivalent examination.

Duration of the project : 03 Years

Interested candidates with the above mentioned qualification can send the applications on a plain paper giving detailed information about the educational qualifications, research experience and published research papers if any via email by 18th January 2021 to the Principal Investigator, Prof .Rajeev Taliyan [Email: rajeev.taliyan@pilani.bits-pilani.ac.in].

Please note that only qualified and suitable candidates will be called for online interview to be held by end of 3rd week of January 2021 and no TA/DA will be paid for the interview. Selected candidate may be permitted to register for Ph.D programme of BITS, Pilani, subject to the fulfillment of the requirements.

PI : Dr. Rajeev Taliyan (Associate Professor)

Related Posts

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Andelyn bio sciences Inc, a leading patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Queen’s University to develop and manufacture AAV9-GM2, a gene therapy…

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

Cellution Biologics Inc, a biologics company focused on developing, manufacturing and commercializing advanced human tissue-based products, announced the completion of its acquisition of the SimpliDerm hydrated human acellular dermal matrix…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

US appeals court sides with Sun Pharma in Lipitor antitrust case

US appeals court sides with Sun Pharma in Lipitor antitrust case

Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad

Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad